Mexican regulator approves Pfizer's COVID-19 pill
Mexican Federal Commission for the Protection against Health Risks (COFEPRIS) authorized Pfizer's Paxlovid treatment for emergency use, as reported by the Mexican regulator on its official website on Friday (local time).
Mexican Federal Commission for the Protection against Health Risks (COFEPRIS) authorized Pfizer's Paxlovid treatment for emergency use, as reported by the Mexican regulator on its official website on Friday (local time), Baku Tribune reports citing Breaking News.
According to the press release, the drug, which combines nirmatrelvir and ritonavir in a tablet, will be used to treat adult patients with mild or moderate COVID-19 symptoms and with the risk of complications.
The head of COFEPRIS, Alejandro Svarch Pérez, explained that this approval represents a new tool in the strategy to combat COVID-19. "This treatment will be crucial to reduce hospitalizations in Mexico, so we are pleased to be the first country in Latin America to authorize its emergency use," added Svarch Perez.
The Rocket and Artillery formations of the Azerbaijan Army conduct live-fire exercises in accordance with the combat training plan for 2021, the Ministry of Defense of Azerbaijan told Baku Tribune.
.jpg&h=67&w=67&zc=1&q=100)
LAST NEWS
Editor's note: Eugene Chausovsky is a senior analyst at the Newlines Institute. Chausovsky previously served as senior Eurasia analyst at the geopolitical analysis firm Stratfor for more than 10 years. His work focuses on political, economic, and security issues pertaining to Russia, Eurasia, and the Middle East.
